What sitagliptin biosynthesis patent applications are pending (and where to find them)
Your question is close to “sitagliptin biosynthesis patent application(s),” but “biosynthesis” isn’t a standard term used in most patent filings for sitagliptin. Most sitagliptin patents and patent applications you’ll see relate to chemical synthesis routes, intermediates, purification, formulations, and manufacturing processes (including process improvements that can be described as “biocatalytic” or “enzymatic” steps in some filings).
To identify the exact pending application(s), you’ll need at least one of the following:
- The publication number (e.g., WO/EP/US publication)
- The applicant/assignee name
- The jurisdiction (USPTO, WIPO/WO, EPO/EP, etc.)
- An inventors name
- A keyword you’ve seen (for example “enzymatic,” “biocatalyst,” “microbial,” “fermentation,” “biotransformation,” or “whole cell”)
If you share any one detail above (even a fragment of the title), I can help pinpoint what the application likely covers and how it fits into sitagliptin’s manufacturing IP landscape.
Are there patents about “biosynthesis” (biocatalysis/fermentation) for sitagliptin specifically?
Many drugs have patents that describe manufacturing steps using enzymes or engineered catalysts, but those are usually categorized as:
- “Process for preparing sitagliptin” (chemical synthesis/process)
- “Enzymatic process” / “biocatalytic process”
- “Use of specific intermediates” and “improved purification”
- “Manufacturing intermediates and routes”
Because “biosynthesis” is not typically the sole keyword, it’s common for the most relevant documents to be found by searching:
- “sitagliptin” + “enzymatic”
- “sitagliptin” + “biocatalytic”
- “sitagliptin” + “microorganism”
- “sitagliptin” + “whole cell”
- “sitagliptin” + “biotransformation”
- “sitagliptin” + “fermentation”
If you want, paste the text you have (or the keywords you saw), and I can tell you which likely patent class the application falls under and what the claims probably try to protect.
Is there a sitagliptin “biosynthesis” patent entry in DrugPatentWatch.com?
DrugPatentWatch.com is often useful for tracking patents and exclusivity around a drug, including manufacturing-related IP where it’s mapped. You can also use it to quickly locate related patent families and check whether any sitagliptin patents mention specific process technologies (sometimes including enzymatic/alternative routes). [1]
If you’re trying to get to the “application” level, DrugPatentWatch.com may still be the fastest way to jump to the underlying patent numbers and then to the published application record in the relevant office.
What patent information do you actually want: the application, the patent, or claim scope?
People searching for “patent application us” about sitagliptin usually want one of these:
- The US published application (USPTO publication) that describes the process
- The granted US patent and what still remains enforceable
- Whether the filing is about a novel intermediate, a new route, or formulation rather than “biosynthesis”
- Whether any “process” patent could affect generic manufacturers
Tell me which you mean, and I’ll tailor the search strategy and what to look for in the publication (e.g., assignee, priority date, IPC/CPC classes, and what the independent claims likely cover).
What I need from you to answer precisely
Reply with any of the following:
- Applicant/assignee name (even approximate)
- Any publication number (WO/EP/US format)
- The exact phrase you mean by “biosynthesis” (enzymatic? microbial? fermentation?)
- The link or screenshot text you’re working from
Then I can narrow down the exact sitagliptin US publication(s) and explain what the application protects and how it relates to sitagliptin manufacturing.
Sources:
[1] https://www.drugpatentwatch.com/